The Feasibility of Ibrexafungerp for the Treatment of Fungal Infections in Patients with Hematological Malignancies

Introduction A significant source of morbidity and mortality in haematological patients, particularly those undergoing hematopoietic stem cell transplantation (HSCT), is invasive fungal diseases (IFD).  Due to non-specific symptoms and a…

Continue ReadingThe Feasibility of Ibrexafungerp for the Treatment of Fungal Infections in Patients with Hematological Malignancies